BAZ1A Antibodies

Santa Cruz Biotechnology features a diverse variety of BAZ1A monoclonal antibodies for research focused on understanding BAZ1A protein functions. BAZ1A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BAZ1A, also known as Bromodomain Adjacent to Zinc Finger Domain 1A, is a critical component involved in chromatin remodeling and gene regulation. BAZ1A plays a significant role in cellular processes such as transcriptional activation and DNA repair, making it essential for maintaining genomic stability. Understanding BAZ1A function is vital for elucidating its implications in various diseases, including cancer and developmental disorders. BAZ1A research continues to reveal new insights into cellular mechanisms and disease pathways. Molecular biology investigations benefit from reliable detection methods to advance understanding of BAZ1A's cellular roles. Current research highlights BAZ1A's importance in DNA damage response and cell cycle regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of BAZ1A's role in health and disease.